Barbara Logan
Psychiatric/Mental Health · New Castle, INNPI 1366676397
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 276 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 276 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Axsome Therapeutics, Inc.$622
- Alkermes, Inc.$600
- Supernus Pharmaceuticals, Inc.$535
- Otsuka America Pharmaceutical, Inc.$402
- Corium, LLC$358
- plus $2K from 30 others
What the payments were for
- Food & beverage$6,080100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $1,114 |
| Axsome Therapeutics, Inc. | 20 | $622 |
| Alkermes, Inc. | 21 | $600 |
| Supernus Pharmaceuticals, Inc. | 26 | $535 |
| Otsuka America Pharmaceutical, Inc. | 22 | $402 |
| Corium, LLC | 22 | $358 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 21 | $356 |
| Jazz Pharmaceuticals Inc. | 7 | $230 |
| Johnson & Johnson | 5 | $195 |
| Neurocrine Biosciences, Inc. | 9 | $170 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $143 |
| Teva Pharmaceuticals USA, Inc. | 2 | $140 |
| Ironshore Pharmaceuticals Inc. | 7 | $124 |
| Noven Therapeutics, LLC | 6 | $118 |
| Lundbeck LLC | 6 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $97 |
| Bausch Health US, LLC | 5 | $87 |
| Indivior Inc. | 4 | $85 |
| GSK | 6 | $83 |
| Neos Therapeutics, LP | 4 | $75 |
| Novo Nordisk | 5 | $67 |
| Lilly USA, LLC | 4 | $61 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Tris Pharma Inc | 3 | $49 |
| Bayer | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Biogen | 1 | $22 |
| Almatica Pharma LLC | 1 | $17 |
| Medtronic | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Exact Sciences | 1 | $15 |
| OWP Pharmaceuticals, Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Boston Scientific | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,092 in reported general payments places this provider in the 90th percentile of 729 psychiatric/mental health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 14 | $317 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $187 |
| Clonazepam | 18 | $27 |
| Alprazolam | 17 | $22 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in New Castle
- Kristin ManningNew Castle$6K
- Kimberly HuffNew Castle$5K
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Paul DuncanJeffersonville$46K
- Morgan StamperConnersville$42K
- Jennifer JimenezUnion Mills$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.